Celldex Therapeutics Inc CLDX:NASDAQ

Last Price$27.87Cboe Previous Close - Real-Time Last Sale as of 3:59PM ET 6/29/22
Cboe Real-Time Quotes
Today's Change0(0.00%)
Bid (Size)$10.58 (100)
Ask (Size)$32.03 (100)
Day Low / HighN/A - N/A
Volume10.00
  • Latest Stories
  • Commentary and Analysis
Celldex Therapeutics Says First Patient Dosed in Phase 2 Clinical Trial of Investigational Chronic Skin Disorder Treatment
11:11AM ET 6/21/2022 MT Newswires

Celldex Therapeutics (CLDX) said Tuesday it has dosed the first patient in the phase 2 clinical trial of its investigational treatment, barzolvolimab, in...

-- Earnings Flash (CLDX) CELLDEX THERAPEUTICS Posts Q1 Loss $-0.49
4:15PM ET 5/05/2022 MT Newswires

...

-- Earnings Flash (CLDX) CELLDEX THERAPEUTICS Posts Q1 Revenue $0.2M
4:14PM ET 5/05/2022 MT Newswires

...

-- Earnings Flash (CLDX) CELLDEX THERAPEUTICS Reports Q4 Revenue $0.3M
4:06PM ET 2/28/2022 MT Newswires

...

-- Earnings Flash (CLDX) CELLDEX THERAPEUTICS Reports Q4 Loss $-0.43
4:05PM ET 2/28/2022 MT Newswires

...

Celldex Therapeutics Doses First Patient in Phase 1 Study of Skin Disease Antibody Treatment
9:45AM ET 12/08/2021 MT Newswires

Celldex Therapeutics (CLDX) on Wednesday said that it has commenced dosing in a phase 1 study of CDX-0159 humanized monoclonal antibody for the treatment...

Insider Sell: Celldex Therapeutics
5:44PM ET 11/16/2021 MT Newswires

Diane C. Young, Senior Vice President, Chief Medical Officer, on November 12, 2021, sold 4,600 shares in Celldex Therapeutics (CLDX) for $197,529....

-- Earnings Flash (CLDX) CELLDEX THERAPEUTICS Reports Q3 Revenue $0.2M
4:03PM ET 11/09/2021 MT Newswires

...

-- Earnings Flash (CLDX) CELLDEX THERAPEUTICS Posts Q3 Loss $-0.45
4:03PM ET 11/09/2021 MT Newswires

...

Insider Sell: Celldex Therapeutics
5:58PM ET 11/03/2021 MT Newswires

Cavanaugh Sarah, SVP of Corp Affairs & Admin., on November 01, 2021, sold 7,323 shares in Celldex Therapeutics (CLDX) for $316,804. Following the Form 4...